Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
NCT01029353
Digestive System Diseases, Enterocolitis
Birmingham, Alabama, United States
View Trial DetailsNCT Number: NCT00873847
This observational study tests the feasibility of enrolling subjects and obtaining an amplitude-integrated electroencephalogram (aEEG) within the first 72 hours of life, a second aEEG recording between 72-168 hours of life, and weekly thereafter up to 36 weeks post-menstrual age. It will enroll 85-100 infants between 401-1,000 grams birth weight OR between 23 0/7 and 28 6/7 weeks gestational age born at the 7 participating NICHD Neonatal Research Network sites.
Looking for future studies?
Notify MeUp to 72 hour
All sexes
Observational
Stanford University, Palo Alto, California, United States
Few techniques exist to permit early and accurate prognosis of brain injury in newborns. Cranial ultrasound and magnetic resonance imaging (MRI) have been used to detect structural abnormalities which may be useful in predicting neuromotor and neurocognitive deficits. However, up to 30% of extremely low birth weight infants with normal ultrasounds have adverse outcomes, and MRI is not feasible when an infant is critically ill. Amplitude-integrated electroencephalogram (aEEG) is a non-invasive, bedside instrument which allows real-time monitoring of brain function and may provide additional information for predicting outcomes in extremely premature infants.
This observational study will enroll 85-100 infants between 401-1,000 grams birth weight OR between 23 0/7 and 28 6/7 weeks gestational age born at the 7 participating NICHD Neonatal Research Network sites. Eligible infants will undergo an aEEG recording in the first 72 hours of life, a second aEEG recording between 72-168 hours of life, and weekly thereafter up to 36 weeks post-menstrual age.
The study tests the feasibility of enrolling subjects and obtaining the required aEEG recordings. The information gathered will provide a framework for the design of a potential prospective, observational, multi-center study for prediction of death or neurodevelopmental impairment by 18-22 months of age.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: < 72 hours of age
Time frame: Birth to 36 weeks post menstrual age
Time frame: < 72 hours of age until 36 weeks post menstrual age
Time frame: < 72 hours of age until 36 weeks post menstrual age
Time frame: < 72 hours of age until 36 weeks post menstrual age
NICHD Neonatal Research Network
Network
Cerebral Function Monitoring and Brain Injury in Preterm Infants: Correlation With Neuroimaging Abnormalities and Neurodevelopmental Impairment - a Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01029353
Digestive System Diseases, Enterocolitis
Birmingham, Alabama, United States
View Trial DetailsNCT01030575
Bronchopulmonary Dysplasia, Bronchopulmonary Dysplasia (BPD)
Birmingham, Alabama, United States
View Trial DetailsNCT01203345
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Birmingham, Alabama, United States
View Trial DetailsNCT01223261
Digestive System Diseases, Enterocolitis
Birmingham, Alabama, United States
View Trial Details